FDA prohibits Ranbaxy API plant from producing and distributing products for US market

11:11 AM | January 24, 2014 | Deepti Ramesh

The US Food and Drug Administration (FDA) announced on 23 January that it has notified Ranbaxy Laboratories (Gurgaon, India), that it is prohibited from manufacturing and distributing active...